Avantax Advisory Services’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Avantax Advisory Services's HALO Position: Q2 2025 in Review
Avantax Advisory Services reduced its Halozyme (HALO) stake by 46% in Q2 2025, selling an estimated $243K and leaving 5,058 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.
Avantax Advisory Services first reported a position in HALO in Q3 2024 and has held it in 4 quarters since. The position peaked at $595K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.
- Avantax Advisory Services held 5,058 shares of Halozyme worth $263K as of Q2 2025.
- Avantax Advisory Services sold 4,263 Halozyme shares in Q2 2025, an estimated $243K.
- Halozyme made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #2016 holding.
- Avantax Advisory Services first reported a position in Halozyme in Q3 2024 and has held it in 4 quarters since.
- Avantax Advisory Services's Halozyme position peaked at $595K in Q1 2025.
- 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.
Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.